PagerDuty Expands International Presence to Japan
In Partnership with Japan Cloud, New Entity Supports Rapid Regional Growth TOKYO & SAN FRANCISCO--(BUSINESS…
4 years ago
Embleema and CDISC Partner to Develop Standards for Cell and Gene Therapy Product Monitoring
Establishing Standards for Experimental Assays and Bioinformatics Protocols Aim at Accelerating Development and Availability of…
4 years ago
Renesas Will Demonstrate the First Working Silicon Based on the Recently Debuted Arm Cortex-M85 Processor
Microcontroller Leader to Showcase Performance, High Integration and Security Advances at Embedded World 2022 Exhibition…
4 years ago
Apple Expands Today at Apple Creative Studios, Providing New Opportunities to Young Creatives
Select Apple Store locations across the globe will host all-new Creative Studios sessions open to…
4 years ago
KKR Leads $200+ Million Growth Investment in Enterprise Identity Protection Leader Semperis
Semperis experiencing hyper-growth attributed to its solutions' unique capability to defend and recover from directory-based…
4 years ago
Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format
BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a…
4 years ago
‘Scaling Hong Kong to the Nordics’ Concludes its Delegation Visit to Finland, Sweden and Denmark, Meeting Local Companies and Investors to Explore Business Opportunities in Nordic Markets
HONG KONG SAR - Media OutReach - 24 May 2022 - “Scaling Hong Kong to…
4 years ago
Gilat Satellite Networks to Present at the 2022 LD Micro Invitational Conference
Presentation will take place on Wednesday, June 8 at 2:30 PT PETAH TIKVA, Israel, May…
4 years ago
MoneyLion and AEON Consortium Obtain Approval for Malaysian Digital Banking License
Digital Finance Leader MoneyLion Expands Enterprise Data and Technology Capabilities with AEON Group, One of…
4 years ago
LUXA BIO Announces First Participant Dosed in Phase 1/2a Clinical Trial of Adult RPESC-RPE-4W for Dry Age-related Macular Degeneration
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul,…
4 years ago